Chinese vaccine: 4 countries ready for trials
China has ramped up its efforts in the global race of developing a vaccine for COVID-19 and as per media reports, four more nations have been given the go-ahead to start the last-stage clinical trials of vaccine candidates developed by Sinovac Biotech and China National Biotec Group (CNBG).
- Sep 7, 2020
Another inactivated vaccine developed by The Wuhan Institute of Biological Products can be made commercially available by late December 2020, as per Liu Jingzhen, who is the head of the state-owned Chinese company Sinopharm. As of now, this Chinese vaccine candidate is in its Phase III of human trials, which are the critical, last stage trials before a vaccine candidate is given regulatory approvals.
About The Author -